Nexavar® (sorafenib) Tablets

Given Nexavar’s efficacy in two difficult-to-treat cancers, we, together with our partner Bayer, are implementing a clinical development program designed to access Nexavar’s applicability across multiple tumor types, including breast, thyroid, lung, colorectal, and ovarian cancers, and as an adjuvant therapy for liver and kidney cancer.